Transient Activation of the PI3K-AKT Pathway by Hepatitis C Virus to Enhance Viral Entry

University of Southern California, United States
Journal of Biological Chemistry (Impact Factor: 4.57). 10/2012; 287(50). DOI: 10.1074/jbc.M112.414789
Source: PubMed


The PI3K-AKT signaling pathway plays an important role in cell growth and metabolism. Here we report that HCV transiently activates the PI3K-AKT pathway. This activation was observed as early as 15 minutes post-infection, peaked by 30 minutes, and became undetectable at 24 hours post-infection. The activation of AKT could also be mediated by UV-inactivated HCV, HCV pseudoparticle (HCVpp) and the ectodomain of the HCV E2 envelope protein. Since antibodies directed against CD81 and claudin-1, but not antibodies directed against SR-BI or occludin, could also activate AKT, the interaction between HCV E2 and its two co-receptors CD81 and claudin-1 likely triggered the activation of AKT. This activation of AKT by HCV was important for HCV infectivity, as the silencing of AKT by siRNA or the treatment of cells with its inhibitors or with the inhibitor of its upstream regulator PI3K significantly inhibited HCV infection, whereas the expression of constitutively active AKT enhanced HCV infection. The PI3K-AKT pathway is likely involved in HCV entry, as the inhibition of this pathway could inhibit the entry of HCVpp but not the VSV pseudoparticle (VSVpp) into cells. Furthermore, the treatment of cells with the AKT inhibitor AKT-V prior to HCV infection inhibited HCV infection whereas the treatment after HCV infection had no obvious effect. Taken together, our studies indicated that HCV transiently activates the PI3K-AKT pathway to facilitate its entry. These results provide important information for understanding HCV replication and pathogenesis and raised the possibility of targeting this cellular pathway to treat HCV patients.

Download full-text


Available from: Yongjun Tian,
72 Reads
    • ". The activation of p21-activated kinase 1 (PAK1) by p70 S6 kinase during HCV infection was proposed to contribute to the PI3K-mediated regulation of HCV infection [31]. Activation of the PI3K–Akt pathway also required interactions between HCV E2 protein and the CD81–CLDN1 receptor complex [30]. The specific roles of the PI3K–Akt pathway in HCV entry, and the functional relevance in hepatocytes, remain unclear. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Hepatitis C virus (HCV) infection relies on virus-host interactions with human hepatocytes, a context in which host cell kinases play critical roles in every step of the HCV life cycle. During viral entry, cellular kinases, including EGFR, EphA2 and PKA, regulate the localization of host HCV entry factors and induce receptor complex assembly. Following virion internalization, viral genomes replicate on endoplasmic reticulum-derived membranous webs. The formation of membranous webs depends on interactions between the HCV NS5a protein and PI4KIIIα. The phosphorylation status of NS5a, regulated by PI4KIIIα, CKI and other kinases, also acts as a molecular switch to virion assembly, which takes place on lipid droplets. The formation of lipid droplets is enhanced by HCV activation of IKKα. In view of the multiple crucial steps in the viral life cycle that are mediated by host cell kinases, these enzymes also represent complementary targets for antiviral therapy. This article is part of a Special Issue entitled:Inhibitors of Protein Kinases. Copyright © 2015. Published by Elsevier B.V.
    Biochimica et Biophysica Acta 04/2015; 1854(10). DOI:10.1016/j.bbapap.2015.04.011 · 4.66 Impact Factor
  • Source
    • "Thus, it is believed that EGFR promotes CD81-CLDN1 complex formation by inducing CD81 diffusion through HRas activation and facilitates CD81-CLDN1 co-internalization with HCV particles. After interaction with the CD81-CLDN1 complex, the HCV particle also transiently activates the PI3K-AKT pathway to facilitate its entry [71]. Finally, it has also been shown that E2 binding to CD81 induces Rho GTPases signalling which in turn leads to a rearrangement of the actin cytoskeleton and could therefore also affect CD81 mobility at the plasma membrane [72]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Hepatitis C virus (HCV) is an important human pathogen that causes hepatitis, liver cirrhosis and hepatocellular carcinoma. It imposes a serious problem to public health in the world as the population of chronically infected HCV patients who are at risk of progressive liver disease is projected to increase significantly in the next decades. However, the arrival of new antiviral molecules is progressively changing the landscape of hepatitis C treatment. The search for new anti-HCV therapies has also been a driving force to better understand how HCV interacts with its host, and major progresses have been made on the various steps of the HCV life cycle. Here, we review the most recent advances in the fast growing knowledge on HCV life cycle and interaction with host factors and pathways.
    Journal of Hepatology 11/2014; 61(1). DOI:10.1016/j.jhep.2014.06.031 · 11.34 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hepatitis C virus (HCV) infects approximately 3% of the world’s population. Currently licensed treatment of HCV chronic infection with pegylated-interferon-α and ribavirin, is not fully effective against all HCV genotypes and is associated to severe side effects. Thus, development of novel therapeutics and identification of new targets for treatment of HCV infection is necessary. Current opinion is orienting to target antiviral drug discovery to the host cell pathways on which the virus relies, instead of against viral structures. Many intracellular signaling pathways manipulated by HCV for its own replication are finely regulated by the oxido-reductive (redox) state of the host cell. At the same time, HCV induces oxidative stress that has been found to affect both virus replication as well as progression and severity of HCV infection. A dual role, positive or negative, for the host cell oxidized conditions on HCV replication has been reported so far. This review examines current information about the effect of oxidative stress on HCV life cycle and the main redox-regulated intracellular pathways activated during HCV infection and involved in its replication.
    International Journal of Molecular Sciences 01/2013; · 2.86 Impact Factor
Show more